Genmab A reported revenue of $1.16B and net income of $0.30B for the quarter ended Jun 2026, down 29.6% year over year. This income statement covers 32 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2018 | Dec2018 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Jan2023 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||
| Revenue | 0.22B | 0.32B | 4.74B | -9.41B | 0.60B | 1.38B | 2.20B | 0.71B | 1.64B | 2.66B | 0.90B | 1.16B | ||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.79B | 0.00B | 0.00B | 0.00B | 0.00B | 0.10B | 0.03B | 0.03B | 0.06B | 0.10B | 0.14B | 0.04B | 0.10B | 0.16B | 0.07B | 0.08B | ||||||||||||||||
| Gross Profit | -0.56B | 4.64B | -9.44B | 0.58B | 1.33B | 2.10B | 0.67B | 1.54B | 2.50B | 0.83B | 1.07B | |||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | -0.10B | -0.13B | -0.18B | -2.09B | -1.11B | -0.34B | -0.70B | -1.03B | -1.41B | -0.36B | -0.72B | -1.08B | -0.44B | -0.46B | ||||||||||||||||||
| Selling, General & AdministrativeSG&A | -0.03B | -0.06B | -0.08B | -0.84B | -0.48B | -0.12B | -0.24B | -0.37B | -0.55B | -0.13B | -0.27B | -0.42B | -0.17B | -0.20B | ||||||||||||||||||
| Restructuring CostsRestructuring | -0.04B | -0.04B | -0.04B | -0.04B | -0.03B | |||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.00B | -0.03B | -0.03B | -0.02B | -0.10B | -0.14B | -0.04B | -0.10B | -0.16B | -0.07B | -0.08B | |||||||||||||||||||||
| Operating ExpensesOpex | -0.13B | -0.20B | -0.26B | -2.93B | -1.62B | -0.49B | -1.03B | -1.54B | -2.15B | -0.53B | -1.09B | -1.66B | -0.72B | -0.78B | ||||||||||||||||||
| Operating IncomeOp. Inc | 0.09B | 0.13B | 0.14B | 1.72B | -2.88B | 0.12B | 0.35B | 0.66B | 0.19B | 0.55B | 1.01B | 0.18B | 0.38B | |||||||||||||||||||
| EBIT | 0.09B | 0.13B | -0.17B | 0.14B | 1.72B | -2.88B | 0.12B | 0.15B | 0.66B | 0.19B | 0.55B | 1.01B | 0.18B | 0.38B | ||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | -0.05B | -0.03B | -0.43B | -0.05B | -0.04B | -0.25B | -0.04B | -0.08B | -0.18B | -0.29B | -0.04B | -0.13B | -0.17B | -0.15B | -0.14B | |||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01B | 0.15B | 0.04B | 1.03B | -0.78B | 0.17B | 0.28B | 0.33B | 0.10B | 0.25B | 0.31B | 0.04B | 0.06B | |||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||
| EBT | 0.05B | 0.25B | 0.27B | 0.16B | 2.70B | -3.81B | 0.25B | 0.56B | 0.81B | 0.24B | 0.67B | 1.15B | 0.07B | 0.29B | ||||||||||||||||||
| Tax ProvisionsTaxes | 0.16B | -0.14B | -0.00B | 0.01B | ||||||||||||||||||||||||||||
| Profit After TaxPAT | 0.03B | 0.19B | 0.27B | 0.13B | 2.13B | -3.08B | 0.19B | 0.40B | 0.58B | 0.20B | 0.53B | 0.93B | 0.05B | 0.30B | ||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 0.05B | 0.25B | 0.27B | 0.16B | 2.70B | -3.81B | 0.25B | 0.20B | 0.81B | 0.24B | 0.80B | 1.15B | 0.07B | 0.29B | ||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 0.05B | 0.25B | 0.27B | 0.16B | 2.70B | -3.81B | 0.25B | 0.20B | 0.81B | 0.24B | 0.80B | 1.15B | 0.07B | 0.29B | ||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -2.27B | 0.25B | 2.53B | 0.07B | 2.59B | 0.16B | 2.86B | -2.54B | 4.71B | 0.20B | 4.79B | 5.30B | 0.80B | 5.75B | 5.68B | 0.29B | ||||||||||||||||
| Net Income towards Common StockholdersNet Income | -2.27B | 0.25B | 2.53B | 0.07B | 2.59B | 0.16B | 2.86B | -2.54B | 3.13B | 0.20B | 3.06B | 5.30B | 0.80B | 5.75B | 5.68B | 0.29B | ||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||
| EPS (Basic) | -35.97 | 4.02 | 40.12 | 1.16 | 41.03 | 2.55 | 45.38 | -38.44 | 47.44 | 3.02 | 46.42 | 80.07 | 12.14 | 86.95 | 87.79 | 4.43 | ||||||||||||||||
| EPS (Diluted) | -35.68 | 3.99 | 39.80 | 1.15 | 40.70 | 2.53 | 45.02 | -38.51 | 47.53 | 3.02 | 46.50 | 81.91 | 12.42 | 88.95 | 90.63 | 4.58 | ||||||||||||||||
| Shares Outstanding | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B | ||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | ||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.07B | 0.07B | 0.07B | 0.06B | ||||||||||||||||||||||||||||
| EBITDA | 0.09B | 0.13B | -0.17B | 0.14B | 1.72B | -2.88B | 0.12B | 0.15B | 0.66B | 0.19B | 0.55B | 1.01B | 0.18B | 0.38B | ||||||||||||||||||
| Interest ExpensesInt Expense | -0.05B | -0.03B | -0.43B | -0.05B | -0.04B | -0.25B | -0.04B | -0.04B | -0.18B | -0.29B | -0.04B | -0.13B | -0.17B | -0.15B | -0.14B | |||||||||||||||||
| Tax Rate | 28.96% | -20.39% | -1.35% | 2.71% |